About ATED Diagnostics
ATED Diagnostics is a private company based in Greenwich, Connecticut, incorporated in 2022 in Israel. It has reported $670,000 raised in one offering on Form D since April 2026. Its chief executive is Jeff Swarz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 24, 2024 | Apr 2, 2026 | $670,000fully sold | 13 | $51,538 | Equity, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ATED Diagnostics's Form D filed Apr 2, 2026.
JC
Sources
- SECATED Therapeutics Ltd. filing history
- CompanyPrivacy policy
- CompanyLeadership